Christopher is a medical oncologist at Border Medical Oncology at the Albury Wodonga Regional Cancer Centre in regional NSW, Australia. In addition to being an Associate Professor at UNSW, he is an Adjunct Professor at the John Richards Centre for Rural Ageing Research , Latrobe University, Wodonga.

After completing training in medical oncology in 2000, Christopher travelled to London to work as a clinical research fellow at Kings College London, Guy’s and St Thomas’ hospital.Whilst at Guy’s he developed an interest in gynaecological oncology and cancer in the older adult. Christopher was appointed to the MRC as the trial physician for the ICON5 study of combination chemotherapy in women with ovarian cancer.  

Christopher has served on the board of the International Society of Geriatric Oncology (SIOG) and was the chair of the national representative committee. He serves on the editorial board of the Journal of Geriatric Oncology. Christopher was chair of the scientific committee of the SIOG annual scientific meeting in Prague in 2016. He was the inaugural chair of the Clinical Oncological Society of Australia (COSA) geriatric interest group).

Christopher serves on the board of COSA and is the president of the Private Cancer Physicians of Australia (PCPA). He is a former board member of the Medical Oncology Group of Australia (MOGA) and the Australian and New Zealand Gynaecological Oncology Group (ANZGOG). He is a member of ASCO, ESMO, IGCS, MOGA, COSA and MASCC.

Christopher is an investigator at the Border Medical Oncology Research Unit and strives to bring clinical trials to patients in regional Australia. He is co-lead of the geriatric oncology pillar of the Victorian Regional Trials Network ReVitalise Project that strives to improve access to clinical trials for patients living in regional Victoria.